Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-08-07 00:00:00 ET · period of report 2024-08-05 · accession 0001610717-24-000416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-07 | 2024-08-05 | RVMD | Clyburn Frank | Dir | A - Grant | $0.00 | +6,932 | 6,932 | New | $0 |
| D | 2024-08-07 | 2024-08-05 | RVMD | Clyburn Frank | Dir | A - Grant | $0.00 | +27.7K | 27.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-05 | A | A | 6,932 | $0.00 | 6,932 | D | — | — | (F1) Includes 6,932 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-08-05 | A | A | 27,744 | $0.00 | 27,744 | D | $42.48 · — to 2034-08-05 | 27,744 Common Stock | (F2) The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date. |